ExodusPoint Capital Management, LP

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1736225 NEW YORK, NY

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,789,151

+$5,243,260 QoQ

Shares Held

61,147

+244.0% QoQ

Ownership

0.089%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#94

of 299 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. RYTM ranks #12 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,789,151	61,147	+244.0%	Shares	Sole	2026-08-14
2026-03-31	$1,545,891	17,775	-76.3%	Shares	Sole	2026-05-14
2025-12-31	$8,043,092	75,141	+86.9%	Shares	Sole	2026-02-17
2023-12-31	$1,847,856	40,197	-73.6%	Shares	Sole	2024-02-14
2023-09-30	$3,494,755	152,443	+872.2%	Shares	Sole	2023-11-13
2023-06-30	$258,579	15,681	-70.8%	Shares	Sole	2023-08-11
2023-03-31	$957,258	53,658	+246.7%	Shares	Sole	2023-05-11
2021-12-31	$154,440	15,475	+33.4%	Shares	Sole	2022-02-11
2021-09-30	$151,509	11,601	-22.4%	Shares	Sole	2021-11-15
2021-06-30	$292,603	14,944	+10.8%	Shares	Sole	2021-08-16
2020-06-30	$300,670	13,483	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.